AEMD stock: buy or sell?
January 17th, 2020
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide.
Should I buy AEMD stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
None of our preferred buy setups matches with Aethlon Medical stock situation right now, hence this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Aethlon Medical stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't detect any rating for AEMD stock for the last 30 days.
AEMD stock analysis
After boosting an astounding 36.59% on Jan 16th, Aethlon Medical closed yesterday at $2.06 and plunged a dreadful -25.36%.
After boosting an astounding 36.59% on January/16, Aethlon Medical closed yesterday at $2.06 and plunged a dreadful -25.36%. From a daily perspective, AEMD is in a short term uptrend after plotting its last bottom ($1.01, on Jan 6th) higher than the previous bottom, and its last top ($3.40, on Jan/16) also over the previous top. Now trading in between its last bottom and last top AEMD might consolidate in a plain range, waiting to break out over $3.40 or down under $1.01.
Aethlon Medical boosted an amazing 66.13% this week. By mid December 2019 AEMD collapsed a spooky -23.81% in just one week. This week was the fourth green week in a row.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $6.89 resistance. Since price and 40-weeks moving average lines crossed down by mid July 2019, AEMD fell $-2.89 per share (-58.38%). Stocks below the 200d moving average line are usually not recommended for average traders.
AEMD stock price history
AEMD stock went public on February 11th, 2002 with a price of $65.001. Since then, AEMD stock sliced a -96.80%, with a yearly average of -5.70%.
1: Adjusted price after possible price splits or reverse-splits.
AEMD stock historical price chart
AEMD stock reached 52-week highs on March at $15.75, and all-time highs 2004-03-09 with a price of 212.5.
AEMD stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. You should not follow the analysts' AEMD stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not detected any price prediction for Aethlon Medical stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAethlon Medical presented extraordinary results for 2018-Q4 on February. Aethlon Medical climbed Earnings per Share (EPS) by 57.10%, beating analysts consensus of $-0.07. Aethlon Medical posted $-0.11.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a spooky slide of -61.84% to $0.15 million USD. In line, its earnings margin (compared to sales) plummed to -3,795.86%, that is $-5.68 million. Aethlon Medical presents anual results in March, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Aethlon Medical TTM sales up to December 2018 were $0.22 and earnings $-5.87 M USD. When comparing this TTM figures with the last reported annuality, we can review Aethlon Medical business evolution since March 2018: Annual sales up to December, compared to lastest yearly report, climbed an exceptional 50.00%. Similarly, profit margin (net income/revenues) boosted at -3,795.86%.
|2013||$1.23 M||-||$-4.89 M-397.6%||-|
|2014||$1.62 M||31.71%||$-13.36 M-824.7%||173.21%|
|2015||$0.76 M||-52.94%||$-6.80 M-891.5%||-49.12%|
|2016||$0.89 M||16.28%||$-4.87 M-549.6%||-28.32%|
|2017||$0.39 M||-55.78%||$-7.28 M-1855.8%||49.34%|
|2018||$0.15 M||-61.84%||$-5.68 M-3795.9%||-21.94%|
|TTM||$0.22 M||50.00%||$-5.87 M-2616.1%||3.38%|
Quarterly financial resultsReported quarter earnings marked $-2.01 million with a profit margin of . Profit margin stayed steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Aethlon Medical sales marked a chilling drop down and collapsed a -100.00%. Looking back to recent quarterly results, Aethlon Medical posted 2 positive quarters in a row.
|2017-Q4||$0.07 M||-||$-1.22 M-1624.1%||-|
|2018-Q1||$0.07 M||0.00%||$-1.32 M-1762.9%||8.55%|
|2018-Q2||$0.15 M||100.00%||$-1.15 M-766.1%||-13.09%|
Aethlon Medical ownershipWhen you are planning to buy shares of a stock, it's worth to overview its ownership structure.
Aethlon Medical shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 11.28% of all shares.
In case of Aethlon Medical stock, 26.27% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AEMD stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Aethlon Medical:
|Market cap||$6.7 M|
|Total shares||3.2 M|
|Float shares||1.3 M|
|- Institutional holdings (%)||26.3%|
|- Insider holdings (%)||11.3%|
|Shares in short selling||0.0%|
|Friday, January 17th, 2020|
|Day range||$1.86 - $2.10|
|Average true range||$0.39|
|50d mov avg||$2.07|
|100d mov avg||$2.87|
|200d mov avg||$4.76|
Aethlon Medical performanceTo better understand Aethlon Medical performance you must becnhmark its gains with other related stocks in same sector or industry. We compared Aethlon Medical against in the following table: